Actelion strives to communicate transparently, based on fact and with consistency. In line with our traditional communication channels, we utilize and leverage our social media channels to highlight our regular news flow, provide direct links into our website and give insight into our scientific expertise and disease areas. We encourage you to meet us on social media, as these channels allow to share a more personal view of us and our company culture. Stay connected and join the conversation!
Like us on our official corporate Facebook page and learn more about orphan diseases, our scientific approach and our corporate social responsibility activities.
On our Twitter channel we share the latest news, provide shareholder information and give insight into our scientific expertise.
On our YouTube channel you can find videos about our Research and Development expertise, our Corporate Social Responsibility activities and other Actelion events.
While we welcome any comments and questions, please be aware that as a pharmaceutical company we follow the stringent regulations that govern our industry and our communication policy. On social media channels where commenting is possible, we do reserve the right to remove any comments that reference to a pharmaceutical companies brand or products, are off-topic or ask for medical advice.
If you experience or know of an adverse event to an Actelion product, please do not report it via social media, but directly via our website.